AI-generated summary
The authors tested a prototype personal light-treatment device with blue LEDs on 11 older adults across two light levels on separate nights, measuring nocturnal melatonin suppression. They report stronger and more sustained melatonin suppression at the higher light level, and suggest the device may be practical and comfortable, though real-life acceptance and effectiveness still need direct testing.
- Participants
- 11
- Who or what was studied
- Eleven healthy older adults aged 51 to 80 years
- Wavelengths
- 470 nm
- Limits stated in the abstract
- The study was small, involved only healthy adults in a laboratory-style setting, and the abstract states that real-world acceptance and effectiveness in people with sleep disorders remain untested.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 470 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Irradiance, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.